Sibanye Gold Ltd ADR (SBSW)vsVersamet Royalties Corporation Common Stock (VMET)
SBSW
Sibanye Gold Ltd ADR
$8.96
-9.40%
BASIC MATERIALS · Cap: $6.48B
VMET
Versamet Royalties Corporation Common Stock
$11.82
-5.39%
BASIC MATERIALS · Cap: $1.26B
Smart Verdict
WallStSmart Research — data-driven comparison
Sibanye Gold Ltd ADR generates 234503% more annual revenue ($129.68B vs $55.27M). VMET leads profitability with a 58.4% profit margin vs -4.0%. VMET earns a higher WallStSmart Score of 58/100 (C).
SBSW
Hold42
out of 100
Grade: D
VMET
Buy58
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 31.6% year-over-year
Keeps 58 of every $100 in revenue as profit
Strong operational efficiency at 90.6%
Revenue surging 594.0% year-over-year
Earnings expanding 573.0% YoY
Conservative balance sheet, low leverage
Areas to Watch
Elevated debt levels
ROE of -16.3% — below average capital efficiency
Earnings declined 38.2%
Negative free cash flow — burning cash
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : SBSW
The strongest argument for SBSW centers on Revenue Growth. Revenue growth of 31.6% demonstrates continued momentum.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 58.4% and operating margin at 90.6%. Revenue growth of 594.0% demonstrates continued momentum.
Bear Case : SBSW
The primary concerns for SBSW are Debt/Equity, Return on Equity, EPS Growth.
Bear Case : VMET
The primary concerns for VMET are P/E Ratio, Market Cap, Altman Z-Score.
Key Dynamics to Monitor
SBSW profiles as a hypergrowth stock while VMET is a growth play — different risk/reward profiles.
VMET is growing revenue faster at 594.0% — sustainability is the question.
VMET generates stronger free cash flow (13M), providing more financial flexibility.
Monitor OTHER PRECIOUS METALS & MINING industry trends, competitive dynamics, and regulatory changes.
Bottom Line
VMET scores higher overall (58/100 vs 42/100), backed by strong 58.4% margins and 594.0% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Sibanye Gold Ltd ADR
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Sibanye Stillwater Limited is a precious metals mining company in South Africa, the United States, Zimbabwe, Canada and Argentina. The company is headquartered in Weltevreden Park, South Africa.
Visit Website →Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is a biopharmaceutical company focused on developing cutting-edge therapeutics for serious diseases, leveraging its proprietary metalloenzyme-based technology platform. The company is committed to addressing significant unmet medical needs in fungal infections and oncology, positioning itself as a leader in therapeutic innovation. With a diverse pipeline bolstered by strategic collaborations and a strong intellectual property portfolio, Viamet is well-prepared to advance its clinical initiatives and enhance shareholder value, aiming to redefine treatment approaches in its specialized therapeutic areas.
Compare with Other OTHER PRECIOUS METALS & MINING Stocks
Want to dig deeper into these stocks?